RegenXBio(DE:RB0)
€7.09+0.38 (+5.60%)
DE:RB0
RegenXBio Revenue
€7.09
At close:+0.38 (+5.60%)
RegenXBio (RB0) Revenue
1 Followers
RegenXBio Revenue
RegenXBio had a revenue of 9.16M in the quarter ending Sep 30, 2026, with -91.52%. This bring the company's revenue in the last twelve months to 153.91M, Decreased 11.79%. In the fiscal year ending Dec 31, 2025, RegenXBio had annual revenue of 170.44M with 104.54% growth.
- Revenue (ttm)
- 153.91M
- Revenue Growth
- -10.99%
- P/S Ratio
- 2.69
- Revenue/Employee
- EUR 459,410
- Employees
- 371
- Market Cap
- EUR 458.23M
Revenue Chart
RegenXBio Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 170.44M | 87.11M | 104.54% |
| Dec 31, 2024 | 83.33M | -6.91M | -7.66% |
| Dec 31, 2023 | 90.24M | -22.48M | -19.94% |
| Dec 31, 2022 | 112.72M | -357.62M | -76.03% |
| Dec 31, 2021 | 470.35M | 315.78M | 204.30% |
| Dec 31, 2020 | 154.57M | 119.33M | 338.70% |
| Dec 31, 2019 | 35.23M | -183.27M | -83.88% |
| Dec 31, 2018 | 218.50M | 208.11M | 2002.42% |
| Dec 31, 2017 | 10.39M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.